Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma

Bibliography

• Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med 2003;349:2241-52
   PubMed Web of Science ®Google Scholar
• Hiyama T, Yoshihara M, Tanaka S, Genetic polymorphisms and esophageal cancer risk. Int J Cancer 2007;121:1643-58
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75:843-54
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-66
   PubMed Web of Science ®Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008;9:102-14
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997-6
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011;108:5003-8
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011;13:423-33
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008;105:10513-18
   PubMed Web of Science ®Google Scholar
• Hasselmann DO, Rappl G, Tilgen W, Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem 2001;47:1488-9
   PubMed Web of Science ®Google Scholar
• Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009;19:43-1
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Yoshioka Y, Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010;285:17442-52
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen Z, Zhang L, Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008;68:26-33
   PubMed Web of Science ®Google Scholar
• Feber A, Xi L, Luketich JD, MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008;135:255-60
   PubMed Web of Science ®Google Scholar
• Chang SS, Jiang WW, Smith I, MicroRNA alterations in head and neck squamous cell carcinoma. Int J Cancer 2008;123:2791-7
   PubMed Web of Science ®Google Scholar
• Avissar M, Christensen BC, Kelsey KT, MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009;15:2850-5
   PubMed Web of Science ®Google Scholar
• Komatsu S, Ichikawa D, Takeshita H, Circulating MicroRNAs in plasma of patients with esophageal squamous cell carcinoma. Br J Cancer 2011;105:104-11
   PubMed Web of Science ®Google Scholar
• Avissar M, McClean MD, Kelsey KT, MicroRNA expression in head and neck cancer associates with alcohol consumption and survival. Carcinogenesis 2009;30:2059-63
   PubMed Web of Science ®Google Scholar
• Fu X, Han Y, Wu Y, Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis. Eur J Clin Invest 2011;41:1245-53
   PubMed Web of Science ®Google Scholar
• Kong KL, Kwong DL, Chan TH, MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2012;61:33-42
   PubMed Web of Science ®Google Scholar
• Silva J, Garcia V, Zaballos A, Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival. Eur Respir J 2011;37:617-23
   PubMed Web of Science ®Google Scholar
• Hu Z, Chen X, Zhao Y, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010;28:1721-6
   PubMed Web of Science ®Google Scholar
• Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumors. 7th edition. Wiley-liss; New York: 2009
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-8
   PubMed Web of Science ®Google Scholar
• Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:2002-7
   Web of Science ®Google Scholar
• Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007;96:644-7
   PubMed Web of Science ®Google Scholar
• He L, He X, Lim LP, A microRNA component of the p53 tumour suppressor network. Nature 2008;447:1130-4
   Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8
   PubMed Web of Science ®Google Scholar
• He L, Thomson JM, Hemann MT, A microRNA polycistron as a potential human oncogene. Nature 2005;435:828-33
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Gal S, Dunlop HM, Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008;141:672-5
   PubMed Web of Science ®Google Scholar
• Wong TS, Liu XB, Wong BY, Mature miR-184 as Potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 2008;14:2588-92
   PubMed Web of Science ®Google Scholar
• Wang J, Chen J, Chang P, MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila Pa) 2009;2:807-13
   PubMed Web of Science ®Google Scholar
• Ng EK, Chong WW, Jin H, Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009;58:1375-81
   PubMed Web of Science ®Google Scholar
• Resnick KE, Alder H, Hagan JP, The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009;112:55-9
   PubMed Web of Science ®Google Scholar
• Hu Z, Chen X, Zhao Y, Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010;28:1721-6
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Lowery AJ, Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010;251:499-505
   PubMed Web of Science ®Google Scholar
• Tsujiura M, Ichikawa D, Komatsu S, Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010;102:1174-9
   PubMed Web of Science ®Google Scholar
• Zhang X, Yan Z, Zhang J, Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol 2011;22:2257-66
   PubMed Web of Science ®Google Scholar